The VA continues to expand access to #Barostim - a novel device therapy option - for Veterans suffering from #heartfailure. We were proud to support Dr. Michael Soult and Dr. Mingxi Dennis Yu and the team at Edward Hines, Jr. VA Hospital on their first Barostim implant.
CVRx | Barostim’s Post
More Relevant Posts
-
As we mark National Stroke Week, it’s a crucial time to raise awareness about stroke prevention and rehabilitation. This week emphasises the importance of timely and effective interventions, including personalised orthotic solutions for stroke survivors. Simplify your custom AFO/KAFO planning with the FIOR & GENTZ Orthosis Configurator. The Orthosis Configurator determines the appropriate system components for your patient by taking the patient data and the load capacity of the selected system joint into account. No cost or log in required. The configurator also creates a complete parts list to allow ease of ordering and manufacturing. Start creating tailored solutions for your patients today: https://lnkd.in/gWVf2nqv Tim Amor, Mairéad Nolan, Charl Botha, Manish Zachariah, Samantha Sudul, Nic Moloney, Kayleigh Strydom, Carel Prinsloo, Anton Kemp, Neelesh Ravikumar, Rene Bartolo, Hannah Buultjens #ÖssurANZ #NeuroOrthotics #fiorgentz #orthotics #afo #kafo
To view or add a comment, sign in
-
#NewsontheGo| 5 Headlines that that should matter to you today ●FG promises to ensure adequate compensation for content creators ●Patient blames UCH for irreversible blindness after radiotherapy ●N20,000 stipend may be increased, says NELFUND Read more | https://lnkd.in/e6P6jFpD #Portable #Gtbank #bbnaijaseason9 #NewsUpdates #rain #NELFUND #news #trending
To view or add a comment, sign in
-
Last week at SOMA, Dr. Paul Parker delivered a compelling presentation on the life-saving impact of the AAJT-S, focusing on its critical role in controlling exsanguinating hemorrhages. 🛡️ Key Highlights from Dr. Parker's Presentation: Critical Need: Non-compressible hemorrhage is a leading cause of preventable battlefield deaths. Rapid Deployment: The AAJT-S can be applied in seconds. Versatility in Application: The AAJT-S is suitable for junctional areas, including the pelvis and abdomen. This versatility makes it a critical tool for managing severe hemorrhages in various combat scenarios. Dr. Parker's presentation underscored the AAJT-S as a minimally invasive solution that offers a critical window for surgical intervention, enhancing patient outcomes on the battlefield. #SOMA2024 #AAJTS #MilitaryMedicine #TraumaCare #stopthebleed
To view or add a comment, sign in
-
Associate Professor & Fellowship Director @ UC Davis | Passionate Educator | Industry Advisor | Ultrasound and Neuropathic Pain Specialist
✈️ "It’s Not The Plane, It’s The Pilot." -- Top Gun Maverick Big shout out to all the #PNS experts who shared their insight, expertise, and experience at the #ASPN2024 lunch debate. This team was spot on with its answers and explanations. 👏 Peripheral nerve stimulation is not just about the technology; it's about the planning, location, and lead placement. It's very much like a pilot flying an approach to land. 🛬 Patient selection, knowledge of patient-specific anatomy, nerve targets, and pre-planning of the approach are all critical. 🎯 Thanks to SPR Therapeutics, Inc. for making this event possible and engaging for speakers and attendees alike. 🙌 We need to continue to advance this vital technology for patients and advocate for payer coverage. 💪 #PainManagement #ChronicPain #HealthcareInnovation #ASPN2024 #PNSPassion American Society of Pain and Neuroscience ASPN David M. Dickerson Tim Deer, MD David Reece DO, FAAPMR, FAANEM Amitabh Gulati Ali Valimahomed, M.D. Kiran V. Patel, MD Mansoor M. Aman, M.D. Christopher Gilmore, MD Maria Bennett Usman Latif Mark Stultz
To view or add a comment, sign in
-
✨ Witness the Transformative Power of MRgFUS! ✨ Before MRgFUS: Mr. Raghunandan struggled with uncontrollable tremors that affected his daily life. Simple tasks became challenging, and his confidence was shaken. After MRgFUS: A life-changing transformation! Watch Mr. Raghunandan's testimonial as he shares his incredible journey to regaining control and rediscovering joy in everyday moments. 👨⚕️ At Royal Care Hospital, we're not just treating symptoms—we're transforming lives. Experience the future of Parkinson's treatment with MRgFUS. 🎥 Tap to see the results for yourself! #RoyalCareHospital #MRgFUS #PatientJourney #TransformingLives"
To view or add a comment, sign in
-
Together, we can continue to ensure that patients with severe aortic stenosis have access to lifesaving therapy. For the millions of eligible patients still untreated, your accurate, early diagnosis and urgent referral to a TAVI heart team are crucial. #ForTheMillionsMore, #OneMillionPatients, #TAVI, #Edwards, #TherapyDevelopment, #AorticStenosis, #HeartValveDisease
To view or add a comment, sign in
-
Sobering statistic: Almost 1 in 3 sarcoma patients wait over 6 months for a diagnosis after their initial appointment. This Sarcoma Awareness Month, we’re determined to change that. Learn the signs, spread the word, and help us ensure faster diagnoses. Your knowledge could be life-saving. Explore more at sarcoma.org.uk/sam #DontDelay #SarcomaAwarenessMonth
To view or add a comment, sign in
-
Experts talking about the Trilogy System and how important it is to have this system available for AR patients. Thanks to Drs. Sam Dawkins and @MattiAdam_MD for this very interesting discussion. #AR #innovation #Jenavalve
From #EuroPCR 2024, this @TCTMD interview between Drs. Sam Dawkins and @MattiAdam_MD examines new innovations in #TAVR with the Jenavalve Trilogy System, the only device with a CE Mark for patients with severe aortic regurgitation. Check it out below! https://lnkd.in/g3vkePDe
To view or add a comment, sign in
-
Exciting new research from a United States military medical centre in Germany shows that our Chattanooga LightForce Therapy significantly reduces pain and improves function in patients with plantar fasciitis. Study Highlights: Participants: 114 adults with PF symptoms for at least 3 months. Methods: Comparison between usual care (UC) and UC combined with photobiomodulation therapy (PBMT) using LightForce EXPi. Results: Significant reduction in pain and improved function within the first 3 weeks, sustained up to 6 months. Conclusion: High-power laser treatment added to usual care leads to better patient outcomes with no adverse effects. Read the full study to learn how LightForce Therapy can enhance patient care and outcomes. Read More on PubMed: https://lnkd.in/dUYrpxQx #LightForceTherapy #PlantarFasciitis #PainManagement #ClinicalResearch #PhysicalTherapy #HealthcareInnovation #LaserTherapy #PatientCare #enovis_nordic #enovis_international
To view or add a comment, sign in
13,118 followers